Salvatore Rametta, MD

Hybrid Revascularization Using Percutaneous Coronary Intervention and Robotically Assisted Minimally Invasive Direct Coronary Ar

08/01/2008

Daniel Swistel , MD;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Scott J. Belsey , MD;

Raj R. Makkar , MD;

Claude Simon , MD;

Varinder Singh , MD;

Joseph DeRose , MD;

Salvatore Rametta , MD;

Thomas J. Nero , MD;

James R. Wilentz , MD;

Minimally invasive direct coronary artery bypass (MIDCAB) has been successfully used to treat isolated lesions of the left anterior descending (LAD) artery by operating on the beating heart without cardiopulmonary bypass (CPB) with excellent...

Minimally invasive direct...

08/01/2008

Journal of Invasive Cardiology

New Heparin Dosing Regimen for Diabetics Undergoing Percutaneous Coronary Intervention

08/01/2008

Gregory Valania , MD;

James R. Wilentz , MD;

Joseph Aragon , MD;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Aslam Khan , MD;

Raj R. Makkar , MD;

Howard Levitt , MD;

Varinder Singh , MD;

Amit Kamra , MD;

Salvatore Rametta , MD;

Unfractionated heparin is the primary anticoagulant administered prior to percutaneous coronary intervention (PCI) to prevent the generation of thrombin at the site of balloon-induced arterial injury and to reduce the thrombogenicity of the...

Unfractionated heparin is the...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Pre-procedural Administration of Aminophylline Does
Not Prevent AngioJet Rheolytic Thrombectomy-induced Bradyarrhythmias

08/01/2008

Varinder Singh , MD;

Salvatore Rametta , MD;

Gregory Valania , MD;

Zlata Platzman ;

James R. Wilentz , MD;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Raj R. Makkar , MD;

Percutaneous coronary intervention (PCI) on thrombus-containing lesions represents a clinical challenge to the interventional cardiologist, since thrombus has been identified as a predictor of adverse outcome.1,2 While attempting to...

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology